Lisa holds an R.Ph. in Pharmacy from the Massachusetts College of Pharmacy in Boston, MA. Lisa is Principal of Daedal Regulatory Strategies, LLC, a consultancy specializing in navigating complex regulatory and scientific issues involving interactions with the FDA. In her previous role as the Vice President of Sciences and Regulatory Affairs at the Association for Accessible Medicines (AAM), she assists with the development of scientific affairs initiatives and member communications and training opportunities. She is involved with facilitating discussions and efforts with FDA, law makers and other industry stakeholders on numerous topics that impact the generic and biosimilar industry.